Host factors impact in early phases of HIV-1 infection
宿主因素对 HIV-1 感染早期阶段的影响
基本信息
- 批准号:6745507
- 负责人:
- 金额:$ 25.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-02-15 至 2006-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The obligated insertion of the HIV-1 genome into the host chromosomal DNA is one of the features that differentiates retroviruses from other viruses. In the nucleus, viral and cellular factors cooperate in order to ensure the correct integration of viral DNA in the host chromatin. Moreover repair of the insertion site is fundamental in order to achieve a productive infection. Among the several DNA repair pathways the cell is equipped with, some have been tested both in vitro as well as in vivo for their ability to promote integration gap repair. We have demonstrated the interaction of integrase with two different cellular processes, a proteasome degradation pathway (N-end rule) and a DNA repair pathway (post-replication repair/translesion). These two pathways share the activity of the key molecule, Rad6. We have shown by mutagenesis of integrase, that elements that determine its N-end rule dependent stability, are significant in HIV-1 infection. The aim of this proposal is to investigate to what extent the two pathways influence the early steps of HIV-1infection with special emphasis dedicated to integration. Initially we will determine which phase within the early steps of viral life cycle is inhibited by mutations in the first position of integrase, since this residue is key to its degradation. Furthermore we will analyze the contribution of Rad6 to both integrase stability as well as to the phenotype observed in the context of the viral mutants. DNA repair is essential for HIV-1infection. To date the post-replication DNA repair pathway has not yet been implicated in retroviral integration other than by our observation that there is a direct interaction between one of its principal components, hRadl 8, and integrase, hRadl 8 also binds hRad6. The role hRadl 8 in HIV-1 replication will be studied by infection of cells overexpressing this protein or molecules that inhibit its endogenous expression. The steps mostly affected by these treatments will be identified by real-time PCR, and the effect on the actual DNA gap repair at the insertion junctions will be assessed as well. The results of the experiments described in this proposal are expected to provide us with a set of information about the influence of these two intercrossing cellular pathways on HIV-1 replication. Moreover we will learn whether interfering with the Nend rule and post-replication DNA repair/translation can eventually render the host cell resistant to infection, and thus qualify the two pathways as potential targets for anti-retroviral therapy.
描述(由申请方提供):HIV-1基因组强制插入宿主染色体DNA是逆转录病毒区别于其他病毒的特征之一。在细胞核中,病毒和细胞因子合作以确保病毒DNA正确整合到宿主染色质中。此外,为了实现生产性感染,插入部位的修复是基本的。在细胞具备的几种DNA修复途径中,一些已经在体外和体内测试了它们促进整合缺口修复的能力。我们已经证明了整合酶与两个不同的细胞过程,蛋白酶体降解途径(N-末端规则)和DNA修复途径(复制后修复/translesion)的相互作用。这两种途径共享关键分子Rad 6的活性。我们已经通过整合酶的诱变表明,决定其N-末端规则依赖性稳定性的元件在HIV-1感染中是重要的。本建议的目的是调查这两种途径在多大程度上影响HIV-1感染的早期步骤,特别强调整合。最初,我们将确定病毒生命周期早期阶段的哪个阶段受到整合酶第一个位置突变的抑制,因为该残基是其降解的关键。此外,我们将分析Rad 6对整合酶稳定性以及在病毒突变体背景下观察到的表型的贡献。DNA修复在HIV-1感染中是必不可少的。迄今为止,复制后DNA修复途径尚未涉及逆转录病毒整合,除了我们观察到其主要组分之一hRadl 8和整合酶之间存在直接相互作用,hRadl 8也结合hRad 6。hRadl 8在HIV-1复制中的作用将通过感染过表达该蛋白或抑制其内源性表达的分子的细胞来研究。将通过实时PCR鉴定受这些处理影响最大的步骤,并评估对插入连接处实际DNA缺口修复的影响。在这个建议中描述的实验结果,预计将为我们提供一组信息的影响,这两个交叉的细胞途径对HIV-1复制。此外,我们还将了解干扰Nend规则和复制后DNA修复/翻译是否最终能使宿主细胞对感染产生抗性,从而使这两种途径成为抗逆转录病毒治疗的潜在靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LUBBERTUS C MULDER其他文献
LUBBERTUS C MULDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LUBBERTUS C MULDER', 18)}}的其他基金
HERV proteogenomics of narcotic-driven HIV latency
麻醉药驱动的 HIV 潜伏期的 HERV 蛋白质基因组学
- 批准号:
10675341 - 财政年份:2023
- 资助金额:
$ 25.65万 - 项目类别:
Impact of HERV-K expression on HIV-1 life cycle
HERV-K 表达对 HIV-1 生命周期的影响
- 批准号:
9037680 - 财政年份:2014
- 资助金额:
$ 25.65万 - 项目类别:
Impact of HERV-K expression on HIV-1 life cycle
HERV-K 表达对 HIV-1 生命周期的影响
- 批准号:
8918002 - 财政年份:2014
- 资助金额:
$ 25.65万 - 项目类别:
Impact of HERV-K expression on HIV-1 life cycle
HERV-K 表达对 HIV-1 生命周期的影响
- 批准号:
8957700 - 财政年份:2014
- 资助金额:
$ 25.65万 - 项目类别:
Impact of HERV-K expression on HIV-1 life cycle
HERV-K 表达对 HIV-1 生命周期的影响
- 批准号:
8730823 - 财政年份:2014
- 资助金额:
$ 25.65万 - 项目类别:
Impact of HERV-K expression on HIV-1 life cycle
HERV-K 表达对 HIV-1 生命周期的影响
- 批准号:
9309282 - 财政年份:2014
- 资助金额:
$ 25.65万 - 项目类别:
Genome stability function of APOBEC3 retroviral restriction factors
APOBEC3逆转录病毒限制因子的基因组稳定性功能
- 批准号:
8309218 - 财政年份:2011
- 资助金额:
$ 25.65万 - 项目类别:
Genome stability function of APOBEC3 retroviral restriction factors
APOBEC3逆转录病毒限制因子的基因组稳定性功能
- 批准号:
8209618 - 财政年份:2011
- 资助金额:
$ 25.65万 - 项目类别:
Genome stability maintenance factors in early HIV-1 infection
早期HIV-1感染中的基因组稳定性维持因素
- 批准号:
7846591 - 财政年份:2009
- 资助金额:
$ 25.65万 - 项目类别:
相似海外基金
CAREER: Next-Generation Flow Cytometry - A New Approach to Cell Heterogeneity
职业:下一代流式细胞术 - 细胞异质性的新方法
- 批准号:
2422750 - 财政年份:2024
- 资助金额:
$ 25.65万 - 项目类别:
Standard Grant
BioSynth Trust: Developing understanding and confidence in flow cytometry benchmarking synthetic datasets to improve clinical and cell therapy diagnos
BioSynth Trust:发展对流式细胞仪基准合成数据集的理解和信心,以改善临床和细胞治疗诊断
- 批准号:
2796588 - 财政年份:2023
- 资助金额:
$ 25.65万 - 项目类别:
Studentship
Omics, Bioinformatics and Flow Cytometry Core
组学、生物信息学和流式细胞术核心
- 批准号:
10630580 - 财政年份:2023
- 资助金额:
$ 25.65万 - 项目类别:
High-parametric flow cytometry cell sorter for human immunology studies.
用于人类免疫学研究的高参数流式细胞仪细胞分选仪。
- 批准号:
10632888 - 财政年份:2023
- 资助金额:
$ 25.65万 - 项目类别:
Time-lapse Flow Cytometry for Kinetic Profiling of T-Cell Function
用于 T 细胞功能动力学分析的延时流式细胞术
- 批准号:
10699148 - 财政年份:2023
- 资助金额:
$ 25.65万 - 项目类别:
Establishment of diagnostic method for pleural effusion in malignant pleural mesothelioma by flow cytometry focusing on cell cycle
以细胞周期为中心的流式细胞术诊断恶性胸膜间皮瘤胸腔积液的方法的建立
- 批准号:
23K15563 - 财政年份:2023
- 资助金额:
$ 25.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Spectral Configured Bigfoot Sorter for Salk Institute Flow Cytometry Core
用于索尔克研究所流式细胞术核心的光谱配置 Bigfoot 分选机
- 批准号:
10632950 - 财政年份:2023
- 资助金额:
$ 25.65万 - 项目类别: